Longitudinal Cohort of Thrombosis and Hemostasis Diseases

Launched by PEKING UNIVERSITY PEOPLE'S HOSPITAL · Dec 5, 2024

Keywords

ClinConnect Summary

This clinical trial is studying various blood disorders, specifically focusing on conditions that affect how blood clots, such as Immune Thrombocytopenia and Hemophilia, among others. The goal is to gather information about these diseases in Chinese patients, including how often they occur, the factors that might increase the risk of developing them, the treatments used, and the costs associated with medical care. Researchers will collect data from patient records and follow up with participants over time through questionnaires to understand their health outcomes better.

To be eligible for this study, participants must have a diagnosed blood clotting disorder. However, individuals who cannot provide long-term health information, or those with serious other health issues, substance abuse problems, or mental illnesses that might interfere with their participation, will not be included. If you choose to participate, you can expect to share your medical history and treatment experiences, which will help improve understanding and treatment of these conditions in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who were diagnosed as thrombosis and hemostasis diseases.
• Exclusion Criteria:
• • Long-term follow-up information for patients is not available for any reason, such as not being available or having a serious concomitant disease.
• • Patients with alcohol and drug addictions or mental illness affect their ability to comply with study requirements.
• • According to the investigator, there are conditions that may endanger the patient's safety or affect his/her compliance.